TrademarkDir
OVAREST
DEAD

Serial Number

86400353

Owner

ENTERIS BIOPHARMA, INC.

Attorney

David J. Dykeman

First Use Date

Jul 17, 2017

Filing Date

Sep 19, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OVAREST Trademark

Serial Number: 86400353 • Registration: 5330032

OVAREST is a trademark filed by ENTERIS BIOPHARMA, INC. on September 19, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ENTERIS BIOPHARMA, INC. (10 trademarks)

83 FULTON STREET
BOONTON, NJ 07005

Entity Type: 03

Trademark Details

Filing Date

September 19, 2014

Registration Date

November 7, 2017

First Use Anywhere

July 17, 2017

First Use in Commerce

July 26, 2017

Published for Opposition

February 10, 2015

Cancellation Date

May 17, 2024

Filing History

CANCELLED SEC. 8 (6-YR)
May 17, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 7, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 7, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 5, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 4, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 3, 2017 SUPC
USE AMENDMENT FILED
Sep 25, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 25, 2017 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2017 EXRA
SOU EXTENSION 4 GRANTED
Jun 20, 2017 EX4G
NOTICE OF REVIVAL - E-MAILED
Jun 16, 2017 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jun 16, 2017 TPEX
PETITION TO REVIVE-GRANTED
Jun 16, 2017 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 16, 2017 PROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2017 REAP
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 8, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 8, 2017 ABN6
SOU EXTENSION 4 FILED
Apr 7, 2017 EXT4
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 24, 2016 EXRA
SOU EXTENSION 3 GRANTED
Nov 23, 2016 EX3G
NOTICE OF REVIVAL - E-MAILED
Nov 15, 2016 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Nov 15, 2016 TPEX
PETITION TO REVIVE-GRANTED
Nov 15, 2016 PETG
TEAS PETITION TO REVIVE RECEIVED
Nov 15, 2016 PROA
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 7, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 7, 2016 ABN6
SOU EXTENSION 3 FILED
Oct 7, 2016 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2016 EXRA
SOU EXTENSION 2 GRANTED
Jun 20, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 12, 2016 AITU
NOTICE OF REVIVAL - E-MAILED
May 5, 2016 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
May 5, 2016 TPEX
PETITION TO REVIVE-GRANTED
May 5, 2016 PETG
TEAS PETITION TO REVIVE RECEIVED
May 5, 2016 PROA
SOU EXTENSION 2 FILED
Apr 7, 2016 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2015 EXRA
SOU EXTENSION 1 GRANTED
Sep 8, 2015 EX1G
SOU EXTENSION 1 FILED
Sep 8, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 8, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2015 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 21, 2015 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2015 CNSA
ASSIGNED TO EXAMINER
Jan 6, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2014 NWOS
NEW APPLICATION ENTERED
Sep 23, 2014 NWAP

Related Trademarks

More from this Owner

TOBRATE

TOBRATE

TOBRATE

TOBRATE

TOBRATE

TOBRATE

TOBRATE

TOBRATE

ENTERIS BIOPHARMA, INTELLIGENT SOLUTIONS FOR ORAL DRUG DELIVERY

ENTERIS BIOPHARMA, INTELLIGENT SOLUTIONS FOR ORAL DRUG DELIVERY

ENTERIS BIOPHARMA, INTELLIGENT SOLUTIONS FOR ORAL DRUG DELIVERY

ENTERIS BIOPHARMA, INTELLIGENT SOLUTIONS FOR ORAL DRUG DELIVERY